We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.53B
AUM Growth
+$68.3M
Cap. Flow
+$49.5M
Cap. Flow %
1.96%
Top 10 Hldgs %
16.36%
Holding
1,009
New
121
Increased
515
Reduced
261
Closed
111

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$29.4M
2
AZTA icon
Azenta
AZTA
+$13.7M
3
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$13.2M
4
AMBA icon
Ambarella
AMBA
+$4.63M
5
TER icon
Teradyne
TER
+$3.54M

Top Sells

Rank Stock Value
1
OII icon
Oceaneering
OII
+$17.5M
2
ZBRA icon
Zebra Technologies
ZBRA
+$12.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.2M
4
IPGP icon
IPG Photonics
IPGP
+$7.17M
5
IRBT
iRobot
IRBT
+$7.11M

Sector Composition

Rank Sector Weight
1 Technology 26.96%
2 Industrials 13.04%
3 Healthcare 11.78%
4 Consumer Discretionary 8.78%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
276
Microsoft
MSFT
$3.71T
$2.52M 0.1%
25,503
+14,883
+140% +$1.44M
MRTX
277
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.52M 0.1%
+51,012
New +$1.93M
NVS icon
278
Novartis
NVS
$297B
$2.5M 0.1%
37,011
+13,685
+59% +$944K
EV
279
DELISTED
Eaton Vance Corp.
EV
$2.5M 0.1%
47,836
+36,772
+332% +$2.03M
IOVA icon
280
Iovance Biotherapeutics
IOVA
$2.87B
$2.46M 0.1%
192,419
-17,911
-9% -$262K
THO icon
281
Thor Industries
THO
$4.14B
$2.46M 0.1%
25,287
+161
+0.6% +$16.4K
SRNE
282
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2.46M 0.1%
+341,852
New +$2.33M
ADAP
283
DELISTED
Adaptimmune Therapeutics
ADAP
$2.44M 0.1%
205,701
-25,648
-11% -$320K
ONC
284
BeOne Medicines Ltd
ONC
$39.4B
$2.43M 0.1%
15,823
-3,927
-20% -$700K
AZN icon
285
AstraZeneca
AZN
$250B
$2.43M 0.1%
34,545
+8,068
+30% +$580K
DVAX
286
DELISTED
Dynavax Technologies
DVAX
$2.42M 0.1%
158,510
+67,096
+73% +$1.16M
BEN icon
287
Franklin Resources
BEN
$17.2B
$2.42M 0.1%
75,339
+6,595
+10% +$221K
CNA icon
288
CNA Financial
CNA
$14.1B
$2.41M 0.1%
52,754
+789
+2% +$38.1K
BECN
289
DELISTED
Beacon Roofing Supply, Inc.
BECN
$2.4M 0.1%
56,383
+843
+2% +$38.8K
TECD
290
DELISTED
Tech Data Corp
TECD
$2.39M 0.09%
29,060
+435
+2% +$35.8K
PIPR icon
291
Piper Sandler
PIPR
$5.29B
$2.38M 0.09%
124,028
+1,860
+2% +$36.4K
PRGO icon
292
Perrigo
PRGO
$1.78B
$2.38M 0.09%
32,651
-882
-3% -$68K
UNM icon
293
Unum
UNM
$14.3B
$2.38M 0.09%
64,390
+1,910
+3% +$79.7K
OC icon
294
Owens Corning
OC
$12.4B
$2.37M 0.09%
37,334
+1,028
+3% +$71K
SANM icon
295
Sanmina
SANM
$10.9B
$2.36M 0.09%
80,696
+1,209
+2% +$35.5K
FATE icon
296
Fate Therapeutics
FATE
$326M
$2.35M 0.09%
+207,676
New +$2.29M
HOUS
297
DELISTED
Anywhere Real Estate
HOUS
$2.35M 0.09%
102,844
+3,689
+4% +$91.8K
PPC icon
298
Pilgrim's Pride
PPC
$6.54B
$2.32M 0.09%
115,299
+1,728
+2% +$37.1K
MGNX icon
299
MacroGenics
MGNX
$257M
$2.3M 0.09%
111,449
+21,716
+24% +$489K
ROG icon
300
Rogers Corp
ROG
$2.4B
$2.29M 0.09%
20,561
+306
+2% +$35.7K
10 11
12
13 14

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q2 2018 Portfolio in Review

As of Q2 2018, Vident Investment Advisory held 1,009 positions worth $2.53B, up 2.8% from $2.46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Investment Advisory's Q2 2018 filing shows 121 new, 515 increased, 261 reduced and 111 closed positions. Its largest new stake was Arcus Biosciences: 156,139 shares worth $1.91M. The largest sale was Oceaneering, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Vident Investment Advisory's largest Q2 2018 buy was Arcus Biosciences: 156,139 shares worth $1.91M.
  • Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $29.4M increase.
  • Vident Investment Advisory's biggest Q2 2018 reduction was Oceaneering, cutting an estimated $17.5M.
  • Vident Investment Advisory fully exited FIRST TRUST HIGH INCOME LONG/SHORT FUND in Q2 2018, selling an estimated $5.5M.
  • Vident Investment Advisory's ten largest holdings make up 16% of its $2.53B portfolio in Q2 2018.
  • Vident Investment Advisory opened 121 new positions and closed 111 in Q2 2018.
  • Vident Investment Advisory's portfolio value rose 2.8% quarter-over-quarter to $2.53B.

Based on Vident Investment Advisory's 13F filing for Q2 2018, filed 14 Aug 2018.